1. Runowicz CD, Fields AL, Goldberg GL: Promising new therapies in the treatment of advanced ovarian cancer. Cancer 76:2028?2033, 1995
2. Allavena P, Peri G, Di Bello M, Peccatori F, Chiaffarino F, Pirovano P, Mantovani A: Lymphocytes infiltrating ovarian carcinoma: Modulation of functional activity by intraperitoneal treatment with biological response modifiers. Nat Immun Cell Growth Regul 7:230?238, 1988
3. Nio Y, Zighelboim J, Berek JS, Bonavida B: Sensitivity of ovarian tumor cells to effector cells generated by various biological response modifiers. Nat Immun Cell Growth Regul 9:283?296, 1990
4. Hirte HW, Clark DA: Factors determining the ability of cytokine-activated killer cells to lyse human ovarian carcinoma targets. Cell Immunol 136:122?132, 1991
5. Zighelboim J, Nio Y, Berek JS, Bonavida B: Immunologic control of ovarian cancer. Nat Immun Cell Growth Regul 7:216?225, 1988